Back
Novo Nordisk AS 10K Form
Sell
32
NONOF
Novo Nordisk AS
Last Price:
126.15
Seasonality Move:
4.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NONOF News And Ratings
See the #1 stock for the next 7 days that we like better than NONOF
NONOF Financial Statistics
Sales & Book Value
| Annual Sales: | $33.72B |
|---|---|
| Cash Flow: | $5.37B |
| Price / Cash Flow: | 59.39 |
| Annual Sales: | $3.63 |
| Price / Book: | 34.76 |
Profitability
| EPS (TTM): | 2.91420 |
|---|---|
| Net Income (TTM): | $13.05B |
| Gross Margin: | $28.53B |
| Return on Equity: | 89.79% |
| Return on Assets: | 28.81% |
Novo Nordisk AS Earnings Forecast
Key Novo Nordisk AS Financial Ratios
- The Gross Profit Margin over the past 40 years for NONOF is 84.60%.
- The Selling, General & Administrative Expenses for NONOF have been equal to 26.52% of Gross Profit Margin.
- The Research & Development expenses have been 13.97% of Revenue.
- The Interest Expense is 0.65% of Operating Income.
- The Net Earning history of NONOF is 36.03% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 35 years.
Novo Nordisk AS Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | NONOF |
| Website: | novonordisk.com |
Debt
| Debt-to-Equity Ratio: | 0.51 |
|---|---|
| Current Ratio: | 0.94 |
| Quick Ratio: | 0.74 |
Price-to-Earnings
| Trailing P/E Ratio: | 46.66 |
|---|---|
| Forward P/E Ratio: | 0 |
NONOF Technical Analysis vs Fundamental Analysis
Sell
32
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a Sell
The current Novo Nordisk AS [NONOF] share price is $126.15. The Score for NONOF is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.